Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer

PURPOSE: Epidemiologic data from several populations suggest that metformin may decrease cancer risk and mortality in patients with colorectal cancer (CRC) and type II diabetes mellitus (DM). Although type II DM and CRC are major health problems in the Middle East, no investigations have been perfor...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Glob Oncol
Egile Nagusiak: Al Omari, Amal, Abdelkhaleq, Hadeel, Al-Hussaini, Maysa, Turfa, Rim, Awad, Nour, Hassan, Manal M., Alfaqih, Mahmoud A., Garrett, Christopher R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2018
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6223523/
https://ncbi.nlm.nih.gov/pubmed/30084749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JGO.18.00018
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak